the blend combines BPC-157 and TB-500 in a single co-lyophilized vial for combined research protocols
Tesamorelin: FDA-approved as Egrifta and Egrifta WR, but only for visceral fat reduction in HIV-associated lipodystrophy
Our 5mg+5mg vials contain 99%+ pure peptides verified by third-party testing for reliable, reproducible results
BPC-157, which stands for Body Protection Compound-157, is a powerful regenerative sequence of amino acids
TB-500, the 43-amino acid form of Thymosin Beta-4 originally isolated from bovine thymus, serves as the dominant G-actin sequestering protein in mammalian cells, orchestrating cytoskeletal dynamics that underlie cellular migration, tissue remodeling, and cardiovascular protection while activating integrin-linked kinase pathways essential for cell survival and repair
The meeting is Nov 6-7 in San Diego